Norinchukin Bank The Grows Stock Position in Colgate-Palmolive Company $CL

Key Points

• Norinchukin Bank increased its holdings in Colgate-Palmolive by 15.1%, now owning 43,071 shares valued at approximately $4,036,000.
• A significant portion of Colgate-Palmolive stock, about 80.41%, is held by institutional investors, with notable increases in stakes from firms like Westend Capital Management and Cornerstone Planning Group.
• Colgate-Palmolive reported an earnings per share of $0.92 for the last quarter, exceeding analysts' expectations and reflecting a 1.0% increase in revenue compared to the previous year.

Norinchukin Bank The lifted its holdings in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 15.1% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 43,071 shares of the company's stock after buying an additional 5,645 shares during the period. Norinchukin Bank The's holdings in Colgate-Palmolive were worth $4,036,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of the business. Integras Partners LLC raised its holdings in shares of Colgate-Palmolive by 5.2% during the 1st quarter. Integras Partners LLC now owns 30,030 shares of the company's stock worth $2,814,000 after buying an additional 1,471 shares in the last quarter. CW Advisors LLC increased its holdings in Colgate-Palmolive by 7.6% in the 1st quarter. CW Advisors LLC now owns 171,158 shares of the company's stock worth $16,022,000 after purchasing an additional 12,089 shares in the last quarter. Summit Financial LLC increased its holdings in Colgate-Palmolive by 1.9% in the 1st quarter. Summit Financial LLC now owns 14,399 shares of the company's stock worth $1,349,000 after purchasing an additional 265 shares in the last quarter. United Asset Strategies Inc. grew its position in shares of Colgate-Palmolive by 3.8% in the 1st quarter. United Asset Strategies Inc. now owns 115,624 shares of the company's stock valued at $10,834,000 after buying an additional 4,186 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD grew its position in shares of Colgate-Palmolive by 18.3% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 34,009,078 shares of the company's stock valued at $3,186,651,000 after buying an additional 5,269,140 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have commented on CL. Wall Street Zen lowered Colgate-Palmolive from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th. Citigroup reduced their price target on Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating on the stock in a research report on Monday, August 4th. JPMorgan Chase & Co. reduced their price target on Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating on the stock in a research report on Monday, August 4th. Morgan Stanley reduced their price target on Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating on the stock in a research report on Monday, August 4th. Finally, UBS Group cut their target price on Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating on the stock in a research report on Thursday, July 17th. Seven equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $98.92.

Colgate-Palmolive Stock Down 2.1%

Colgate-Palmolive stock traded down $1.8050 during mid-day trading on Monday, reaching $84.1350. The stock had a trading volume of 4,311,062 shares, compared to its average volume of 5,215,308. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89. Colgate-Palmolive Company has a fifty-two week low of $82.40 and a fifty-two week high of $109.30. The stock's 50-day simple moving average is $87.60 and its 200-day simple moving average is $89.96. The firm has a market capitalization of $68.00 billion, a PE ratio of 23.63, a price-to-earnings-growth ratio of 4.47 and a beta of 0.35.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, beating analysts' consensus estimates of $0.89 by $0.03. The company had revenue of $5.11 billion for the quarter, compared to analyst estimates of $5.03 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The company's revenue for the quarter was up 1.0% on a year-over-year basis. During the same quarter last year, the company earned $0.91 earnings per share. On average, sell-side analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were paid a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date was Friday, July 18th. Colgate-Palmolive's dividend payout ratio is 58.43%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.